11 Systemic Lupus Erythematosus Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Systemic Lupus Erythematosus Studies in Rochester

NCT00830557Recruiting

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic c...

Rochester, MN20,000 participantsMayo Clinic

View Study Details

NCT02573753Recruiting

The Effects of Sleep on Human Microbiota: Implications for Health and Disease

The aggregate of microorganisms inhabiting the human body can be regarded as a dynamic reflector of both healthy and disease states, altering in response to changes in the environment. This may preced...

Rochester, MNNA5,000 participantsMayo Clinic

View Study Details

NCT07691970Recruiting

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

The purpose of this study is to provide continued access to anifrolumab to eligible participants who are continuing to derive clinical benefit from treatment at the end of a parent clinical study, as ...

Rochester, MNPHASE31,072 participantsAstraZeneca

View Study Details

NCT04124848Recruiting

Obstructive Sleep Apnea Among Somali-Americans

The investigators seek to advance the understanding of obstructive sleep apnea as it relates to different ethnic origins as well as sex differences. The investigators will compare Somali patients with...

Rochester, MN600 participantsMayo Clinic

View Study Details

NCT06570798Recruiting

A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...

Rochester, MNPHASE2220 participantsAmgen

View Study Details

NCT03307330Recruiting

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea

Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue...

Rochester, MN120 participantsMayo Clinic

View Study Details

NCT06975787Recruiting

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

This study is researching a particular group of experimental drugs administered for a short period in the treatment of participants with Lupus Nephritis (LN). The main aim of the current study is to ...

Rochester, MNPHASE190 participantsRegeneron Pharmaceuticals

View Study Details

NCT07113288Recruiting

Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study

The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher...

Rochester, MN70 participantsInspire Medical Systems, Inc.

View Study Details

NCT06261034Recruiting

A Study of Sex Differences in Neurocirculatory Control

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA)....

Rochester, MN60 participantsMayo Clinic

View Study Details

NCT06381115Recruiting

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. ...

Rochester, MNNA40 participantsMayo Clinic

View Study Details

NCT06613360Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE)....

Rochester, MNPHASE124 participantsCullinan Therapeutics Inc.

View Study Details

About Systemic Lupus Erythematosus Clinical Trials in Rochester

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, blood cells, brain, heart, and lungs. It is characterized by periods of flares and remission. Treatment includes antimalarials, immunosuppressants, corticosteroids, and biologics like belimumab.

There are currently 11 systemic lupus erythematosus clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 27,296 participants. Research is being sponsored by Mayo Clinic, AstraZeneca, Amgen and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Systemic Lupus Erythematosus Clinical Trials in Rochester — FAQ

Are there systemic lupus erythematosus clinical trials in Rochester?

Yes, there are 11 systemic lupus erythematosus clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What systemic lupus erythematosus treatments are being tested?

The 11 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for systemic lupus erythematosus.

Data updated October 15, 2026 from ClinicalTrials.gov